Search results for: 'sales co pfot'

26 Oct 2021  |  North America  |  Market Research

North American Used Car Growth Opportunities

Lack of New Cars for Sale and Demand for Digital and Contactless Services Influence Growth Strategies

Infographics

×

The COVID-19 pandemic and global shortages of microchips have had a huge negative impact on the North American used car market (the United States and Canada). Factories and dealerships remained closed during lockdowns, which stalled car production and sales. After they reopened, the lack of microchips interrupted car production once more. Although ...

08 May 2020  |  North America  |  Market Outlook

Global Powertrain Outlook, 2020

Diesel’s Share to Continue Decline to Less Than 30% in Europe; EVs Expected to Grow by 3.4% and Hybrids to Decrease by 2.3%; Covid-19 to Bring Global Sales Down by 14.2%

Infographics

×

Key Issues Addressed Key Benefits

This research service provides an in-depth analysis of powertrain technologies and the strategic imperatives of upcoming diesel and gasoline technologies, technology roadmaps, and technology advancements. The study highlights current and future product plans of various manufacturers and their growth potential. It also covers the impact of Covid-19 ...

The global automotive industry is going through a transformation with CASE convergence. Connectivity and autonomous driving features are at the forefront of this transformation. Globally, OEMs are looking to introduce various ADAS features ranging from L0 to L2+. These features are not just safety enhancements but are also viewed as comfort and con...

31 Jul 2023  |  North America  |  Market Research

Global Oncology Diagnostics in IVD Growth Opportunities

By Leveraging Data-driven Solutions, Co-development Opportunities, and Assay Innovation, Clients Can Experience Enhanced Product Performance, Cost-effectiveness, and Improved Decision-making Capabilities

Infographics

×

The global oncology diagnostics in IVD market is expected to witness significant growth, driven by an increase in cancer incidence, technological developments in diagnostic tests, the growing number of screening tests, and supportive government initiatives. Owing to the intense competition in the market, the most prominent companies are investing h...

30 Aug 2018  |  North America  |  Market Research

Future of Vehicle Subscription—Business Models and Opportunities in North America and Europe, 2025

Vehicle Subscription Targets 10% of New Vehicles Sales by 2025

Infographics

×

Frost & Sullivan defines vehicle subscription as a shared mobility service where a customer can get access to temporary vehicle ownership - usually by the month. In other words, it can be described as micro leasing a vehicle for a shorter period. It is also sometimes referred as temporary ownership via renting a new car or leasing a used car. Vehic...

The North American high-voltage circuit breaker market has been analyzed on the basis of the voltage classes: 72.5kV, 115kV, 123kV, 145kV, 170kV, 245kV, 352kV, 550kV, and 800kV. The report is segmented based into the sub-transmission (72.5kV) and transmission (greater than 72.5kV) segments. Based on the construction type, the circuit breaker market...

The global Lithium-ion battery market by application (grid + energy storage, automotive, industrial, and consumer electronics) and by region (North America, Europe, APAC, and Rest-of-the-world) is expected to grow at a compound annual growth rate (CAGR) of 17.9% during 2018–2025. Market growth is fuelled by rising demand for energy storage across t...

This study examines the North American mobile asset management (MAM) market. For the purposes of this study, mobile asset management offerings are defined as solutions that use wireless tracking devices and cellular, location, and sensor technologies to remotely locate and monitor moveable assets that are outside of a companys four walls. Rich data...

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...